Healthcare AI investors focused on Diagnostics
Venture firms, family offices, accelerators, and corporate VCs with explicit thesis exposure to Diagnostics within healthcare AI. Includes lead investors, follow-on participants, and active angels.
The diagnostics sub-vertical encompasses the technologies, hardware, and biochemical tests used to identify diseases, medical conditions, or genetic predispositions. Innovations in this space range from AI-powered pathology software and rapid point-of-care testing devices to complex genomic sequencing panels that enable highly personalized medicine.
264
investors match
Within Diagnostics: top investment stages
Lilly Asia Ventures
VC
AI
T3
Biotech
Diagnostics
LUMO Labs
VC
T3
AI/ML in Healthcare
Diagnostics
Martlet Capital
VC
T3
AI/ML in Healthcare
Biotech
Mayfield Fund
VC
T1
AI/ML in Healthcare
Biotech
Mayo Clinic Ventures
Corporate VC
T3
AI/ML in Healthcare
Biotech
MBX Capital
VC
T3
AI/ML in Healthcare
Biotech
MD One Ventures
VC
T3
Biotech
Diagnostics
Med-Fine Capital
VC
T3
Biotech
Diagnostics
Medical Technology Venture Partners
VC
T3
Diagnostics
Digital Health
Medtronic Ventures
Corporate VC
T3
Diagnostics
Digital Health
MedVenture Partners
VC
T3
Diagnostics
Medical Devices / MedTech
Merck
Corporate VC
T3
AI/ML in Healthcare
Diagnostics
Merck Global Health Innovation Fund
Corporate VC
T3
AI/ML in Healthcare
Diagnostics
MFV Partners
VC
T3
AI/ML in Healthcare
Biotech
Mighty Capital
VC
T3
AI/ML in Healthcare
Diagnostics